机译:Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
Dept Rheumatol,Hosp La Paz;
Hosp Univ Marques Valdecilla,Santander Univ Cantabria;
Hosp Univ La Princesa,Univ Autonoma UAMDept Rheumatol,Complejo Hosp NavarraDept Rheumatol,Hosp SierrallanaDept Rheumatol,Complejo Asistencial Univ LeonDept Rheumatol,Complejo Hosp Univ PontevedraDept Rheumatol,Hosp Bellvitge Princeps EspanyaDept Rheumatol,Hosp Alto DebaDept Rheumatol,Complejo Hosp Univ SantiagoDept Rheumatol,Complexo Hosp Univ VigoDept Rheumatol,Hosp Univ TorreviejaDept Rheumatol,Hosp Univ Lucus AugustiDept Rheumatol,Hosp Parc TauliDept Rheumatol,Hosp Univ EldaDept Rheumatol,Hosp Ramon & Cajal;
Giant cell arteritis; Cranial arteritis; Tocilizumab; Monotherapy; Immunosuppressive drugs; MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS PATIENTS; POLYMYALGIA-RHEUMATICA; DOUBLE-BLIND; METHOTREXATE; EFFICACY; COMBINATION; TRIAL; MANAGEMENT; SAFETY;